Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
AIRO Breast Cancer Group Best Clinical Practice 2022 Update.
Ciabattoni A, Gregucci F, De Rose F, Falivene S, Fozza A, Daidone A, Morra A, Smaniotto D, Barbara R, Lozza L, Vidali C, Borghesi S, Palumbo I, Huscher A, Perrucci E, Baldissera A, Tolento G, Rovea P, Franco P, De Santis MC, Grazia AD, Marino L, Meduri B, Cucciarelli F, Aristei C, Bertoni F, Guenzi M, Leonardi MC, Livi L, Nardone L, De Felice F, Rosetto ME, Mazzuoli L, Anselmo P, Arcidiacono F, Barbarino R, Martinetti M, Pasinetti N, Desideri I, Marazzi F, Ivaldi G, Bonzano E, Cavallari M, Cerreta V, Fusco V, Sarno L, Bonanni A, Mangiacotti MG, Prisco A, Buonfrate G, Andrulli D, Fontana A, Bagnoli R, Marinelli L, Reverberi C, Scalabrino G, Corazzi F, Doino D, Di Genesio-Pagliuca M, Lazzari M, Mascioni F, Pace MP, Mazza M, Vitucci P, Spera A, Macchia G, Boccardi M, Evangelista G, Sola B, La Porta MR, Fiorentino A, Levra NG, Ippolito E, Silipigni S, Osti MF, Mignogna M, Alessandro M, Ursini LA, Nuzzo M, Meattini I, D'Ermo G. Ciabattoni A, et al. Among authors: mangiacotti mg. Tumori. 2022 Jul;108(2_suppl):1-144. doi: 10.1177/03008916221088885. Tumori. 2022. PMID: 36112842
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience.
Mattiucci GC, Valentini C, D'Agostino GR, Augurio A, Capirci C, De Paoli A, Genovesi D, Huscher A, Iannone T, Pani G, Rosetto ME, Sciacero P, Manfrida S, Corazzi F, Fusco V, Luppattelli M, Mangiacotti MG, Melano A, Murino P, Niespolo R, Osti MF, Picardi V, Morganti AG, Valentini V. Mattiucci GC, et al. Among authors: mangiacotti mg. Tumori. 2015 Jan-Feb;101(1):91-7. doi: 10.5301/tj.5000265. Tumori. 2015. PMID: 25712602
Biological optimization of the dose in pancreatic cancer.
Mattiucci GC, D'Agostino G, De Bari B, Mangiacotti MG, Smaniotto D, Trodella L. Mattiucci GC, et al. Among authors: mangiacotti mg. Rays. 2004 Jul-Sep;29(3):301-8. Rays. 2004. PMID: 15603302 Review.
Impact of dose and volume on subcutaneous fibrosis.
De Santis M, Luzi S, Errico A, Frascino V, Mangiacotti MG, Picardi V, Morganti AG. De Santis M, et al. Among authors: mangiacotti mg. Rays. 2005 Apr-Jun;30(2):169-73. Rays. 2005. PMID: 16294910 Review.
Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer.
Cesario A, Margaritora S, Trodella L, Valente S, Corbo GM, Macis G, Galetta D, d'Angelillo RM, Porziella V, Ramella S, Mangiacotti MG, Granone P. Cesario A, et al. Among authors: mangiacotti mg. Lung Cancer. 2002 Aug;37(2):207-12. doi: 10.1016/s0169-5002(02)00075-2. Lung Cancer. 2002. PMID: 12140144 Clinical Trial.
11 results